Nephro Care India Limited is a comprehensive treatment center located in Kolkata, offering a wide range of clinical and lifestyle solutions, as well as renal insufficiency treatment for patients.
Nephro Care is supported by expert doctors, experienced paramedical professionals, and a skilled management team.
Currently, the hospital provides healthcare services to approximately 900 Chronic Kidney Disease patients every month. The hospital has 5 permanent doctors, 10 visiting consultants, and 70 experienced paramedical professionals. These services are delivered from its main Salt Lake clinic, which covers an area of 5,352 square feet, and three satellite clinics located in Salt Lake (HB 113) and Chandannagar, West Bengal.
At present, Nephro Care offers the following services at its clinics – In-house Dialysis Unit, Outpatient Services in areas of Nephrology, Diabetology, Cardiology, Ophthalmology and Neurology, NABL accredited inhouse Pathology, Inhouse Pharmacy, Advance diagnostic facilities, Renal Nutrition department, Home Care, Mukti (Lifestyle Support Program) & Home Dialysis.
For year/ period ended (Rs. in lacs.)
| H1FY23 | FY22 | FY21 | |
|---|---|---|---|
| Total Revenue | 1,709.51 | 342.70 | 183.26 |
| Profit After Tax | 194.24 | -0.98 | 8.87 |
| EPS | 1.94 | (0.03) | 4.44 |
| OPM (%) | 21.33% | 3.67% | 8.47% |
| PATM (%) | 11.36% | (0.29%) | 4.86% |
For year/ period ended ( in Cr.)
| Company Name | Market Cap (Cr.) | Price | P/BV | P/E | Sales (Cr.) FY23 |
Net Profits(Cr.) FY23 |
|---|---|---|---|---|---|---|
The company is engaged in providing healthcare services with renal insufficiency treatment. Based on its super annualized FY24 earnings, the issue appears aggressively priced.
Never Miss IPO Investment